CONTACT US
Email:[email protected]
Address:1288 Purui West Road, Wangcheng Economic and Technological Development Zone, Changsha City, Hunan Province, China
Development path
In November 2019, the company developed a key enzyme for cephalosporin intermediate 7-ACA one-step enzymatic production ----- cephalosporin C acylase was successfully and industrialized, and sales were achieved.

In October 2019, the company's technical invention patents CN105802937A (preparation method of high temperature resistant lipase) and CN105802936A (preparation method of high temperature resistant phytase and high temperature resistant phytase and their applications) were authorized.

In October 2018, the company's enzymatic preparation of ursodeoxycholic acid was listed as a high-tech key project by the Science and Technology Bureau of Wangcheng District, Changsha City, and received special funding support.

In June 2017, the company's enzymatic preparation of ursodeoxycholic acid project was successfully developed and formed a strategic cooperation with Changde Yungang Biotechnology Co., Ltd. and realized the industrialization and sales of ursodeoxycholic acid series enzymes.

In September 2016, the company's enzymatic production of a highly effective oral antibiotic cefprozil research and development project was successful and reached a technical cooperation with the listed company Chongqing Fuan Pharmaceutical. At the same time, antibiotics such as penicillin acylase, penicillin synthase, and deacetylase were industrialized in Ningxia production base.

In August 2016, the company participated in the selection of the second youth innovation and entrepreneurship project in Wangcheng District, Changsha City, and was selected as one of the top ten projects in industrial manufacturing.

In January 2016, the company changed its registered address to Changsha Wangcheng Economic and Technological Development Zone, and changed its name to Hunan Nanbeiwang Biological Technology Co., Ltd. The scope of business increased the production of food and feed additives, as well as the import and export of various commodities and technologies. The registered capital is 2 million yuan.

In June 2015, the company completed the research and development of high temperature resistant phytase for feed, and realized industrialization in the production base of Ningxia Zhongwei Beautiful Industrial Park.

On January 4, 2015, Changsha Nanbeiwang Biological Technology Co., Ltd., the predecessor of Nanbeiwang Biological Technology Co., Ltd., was established in Yannong Comprehensive Building, Changsha High-tech Zone. The company is mainly engaged in biotechnology development services, consulting, exchange services, transfer services; chemical product sales, research and development, etc., with a registered capital of 1 million yuan.
